Results 141 to 150 of about 2,392 (196)

Pretargeted Radioimmunotherapy of Ovarian Cancer with ²²⁵Ac and an Internalizing Antibody. [PDF]

J Nucl Med, 2023
Li X, Lan X, Cai W.
europepmc   +1 more source

Highlight selection of radiochemistry and radiopharmacy developments by editorial board. [PDF]

EJNMMI Radiopharm Chem
Toyohara J, Elsinga PH, Todde S, Li XG, Aime S, Szymanski WC, van der Meulen N, Cleeren F, Schirrmacher R, Yang H, Savio E, Bentaleb N, Zubillaga M, Chaple Gore IF, Bourgeois M, Mukherjee A, Pellico J, Kopka K.   +17 more
europepmc   +2 more sources

Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting. [PDF]

J Nucl Med
Poty S, Ordas L, Dekempeneer Y, Parach AA, Navarro L, Santens F, Dumauthioz N, Bardiès M, Lahoutte T, D'Huyvetter M, Pouget JP.   +10 more
europepmc   +1 more source

Development of a First-in-Class Click Chemistry-Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial. [PDF]

Clin Cancer Res
Srinivasan S, Yee NA, Alečković M, Zakharian M, Mahmoodi A, Wagner S, Nguyen TH, Chawla SP, Guminski AD, Mejía Oneto JM.   +9 more
europepmc   +1 more source

Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer. [PDF]

Nucl Med Biol
Mack KN, Bauer D, Carter LM, Carrasco SE, Atmane MI, Viray TD, Brooks CL, Hollingsworth MA, Radhakrishnan P, Lewis JS.   +9 more
europepmc   +1 more source

Nuclear Imaging of Bispecific Antibodies on the Rise. [PDF]

J Nucl Med
Roohani B, Mendez AS, Dangarwala M, Katz S, Marquez-Nostra B.   +4 more
europepmc   +1 more source

Targeted Nanoboron Delivery Platform for Boron Neutron Capture Therapy in Refractory Solid Tumors. [PDF]

Int J Nanomedicine
Ma Z, Ma Z, Wang X, Li Y, Li L, Li L, Ji P, Yan Q.   +7 more
europepmc   +1 more source

Current landscape and clinical progress of targeted alpha radioimmunotherapy. [PDF]

Am J Nucl Med Mol Imaging
Booth OC, Dhamecha KR, Oderinde OM, Zheng QH.   +3 more
europepmc   +1 more source

Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy [PDF]

core   +1 more source

Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine. [PDF]

Transl Neurodegener
Lopes van den Broek S, Eriksson J, Yang Q, Bucher NM, Schlein E, Balestri LJI, Odell LR, Sehlin D, Syvänen S.   +8 more
europepmc   +1 more source